Literature DB >> 21112185

Smoking history and motivation to quit in smokers with schizophrenia in a smoking cessation program.

Monica C Mann-Wrobel1, Melanie E Bennett, Elaine E Weiner, Robert W Buchanan, M Patricia Ball.   

Abstract

OBJECTIVE: The present study sought to better understand the relationships among smoking history, motivation to change, and smoking cessation outcomes in people with schizophrenia who smoke.
METHOD: We examined smoking and quit history, negative consequences due to smoking, readiness to change, smoking temptation, and confidence to quit in a sample of people diagnosed with schizophrenia or schizoaffective disorder according to DSM-IV criteria who were participating in a larger randomized trial of bupropion SR and a psychoeducational intervention for smoking cessation. Data were collected from June 2003 to May 2005.
RESULTS: At baseline, participants reported high levels of nicotine dependence and daily smoking, as well as multiple recent and lifetime quit attempts that were generally brief in nature. Participants were most concerned about the health effects of smoking and endorsed reasons for smoking related to coping with negative affect and boredom. Most participants reported wanting to quit smoking, but the sample generally reported low levels of confidence in their ability to quit. During the course of participation in the intervention, self-efficacy to quit increased while temptation to smoke decreased; however readiness to quit remained unchanged.
CONCLUSION: Smoking cessation programs for people with schizophrenia should focus on teaching coping skills for negative affect, boredom, and specific "high risk situations" for smoking in addition to education, medication, or nicotine replacement therapy. Further, cessation efforts may benefit from directly addressing low self-efficacy for quitting, rather than readiness for change alone, among people with schizophrenia. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21112185     DOI: 10.1016/j.schres.2010.10.030

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  18 in total

1.  Nicotine-induced activation of caudate and anterior cingulate cortex in response to errors in schizophrenia.

Authors:  Lauren V Moran; Luke E Stoeckel; Kristina Wang; Carolyn E Caine; Rosemond Villafuerte; Vanessa Calderon; Justin T Baker; Dost Ongur; Amy C Janes; A Eden Evins; Diego A Pizzagalli
Journal:  Psychopharmacology (Berl)       Date:  2017-11-27       Impact factor: 4.530

2.  Expanding Cessation Pharmacotherapy Via Videoconference Educational Outreach to Prescribers.

Authors:  Mary F Brunette; Nino Dzebisashvili; Haiyi Xie; Sarah Akerman; Joelle C Ferron; Stephen Bartels
Journal:  Nicotine Tob Res       Date:  2015-08       Impact factor: 4.244

3.  Effects of smoking abstinence on cigarette craving, nicotine withdrawal, and nicotine reinforcement in smokers with and without schizophrenia.

Authors:  Jennifer W Tidey; Suzanne M Colby; Emily M H Xavier
Journal:  Nicotine Tob Res       Date:  2013-10-10       Impact factor: 4.244

4.  Abstinence and Use of Community-Based Cessation Treatment After a Motivational Intervention Among smokers with Severe Mental Illness.

Authors:  Joelle C Ferron; Timothy Devitt; Gregory J McHugo; Jessica A Jonikas; Judith A Cook; Mary F Brunette
Journal:  Community Ment Health J       Date:  2016-03-01

5.  History and Correlates of Smoking Cessation Behaviors Among Smokers With Serious Mental Illness.

Authors:  Su Fen Lubitz; Alex Flitter; E Paul Wileyto; Douglas Ziedonis; Nathaniel Stevens; Frank Leone; David Mandell; John Kimberly; Rinad Beidas; Robert A Schnoll
Journal:  Nicotine Tob Res       Date:  2020-08-24       Impact factor: 4.244

6.  Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset.

Authors:  Romain Rey; Thierry D'Amato; Laurent Boyer; Lore Brunel; Bruno Aouizerate; Fabrice Berna; Delphine Capdevielle; Isabelle Chereau; Gabrielle Chesnoy-Servanin; Hélène Denizot; Jean-Michel Dorey; Caroline Dubertret; Julien Dubreucq; Catherine Faget; Franck Gabayet; Christophe Lancon; Jasmina Mallet; David Misdrahi; Christine Passerieux; Aurélie Schandrin; Franck Schürhoff; Mathieu Urbach; Pierre Vidailhet; Pierre-Michel Llorca; Guillaume Fond
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-07       Impact factor: 5.270

7.  Patterns and Predictors of Changes in Substance Use in Individuals with Schizophrenia and Affective Disorders.

Authors:  Melanie E Bennett; Clayton H Brown; Jason Peer; Lan Li; Alan S Bellack
Journal:  J Dual Diagn       Date:  2012-02-13

8.  Smoking Cessation in Individuals With Serious Mental Illness: A Randomized Controlled Trial of Two Psychosocial Interventions.

Authors:  Melanie E Bennett; Clayton H Brown; Lan Li; Seth Himelhoch; Alan Bellack; Lisa Dixon
Journal:  J Dual Diagn       Date:  2015

9.  Neural Responses to Smoking Cues in Schizophrenia.

Authors:  Lauren V Moran; Jennifer M Betts; Dost Ongur; Amy C Janes
Journal:  Schizophr Bull       Date:  2018-04-06       Impact factor: 9.306

Review 10.  Antidepressants for smoking cessation.

Authors:  John R Hughes; Lindsay F Stead; Jamie Hartmann-Boyce; Kate Cahill; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2014-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.